Xenon Pharmaceuticals Inc. reported earnings results for the fourth quarter ended December 31, 2022. For the fourth quarter, the company reported net loss was USD 37.4 million compared to USD 25.56 million a year ago.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
40.08 USD | -0.64% | -1.32% | -13.15% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.15% | 3.04B | |
+9.04% | 114B | |
+11.37% | 104B | |
-12.36% | 22.41B | |
-1.05% | 22.28B | |
-5.29% | 19.07B | |
-38.29% | 18B | |
-2.53% | 17.89B | |
+8.15% | 14.28B | |
+35.09% | 12.55B |
- Stock Market
- Equities
- XENE Stock
- News Xenon Pharmaceuticals Inc.
- Xenon Pharmaceuticals Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022